Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SANISERVICE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   7.8% 7.8% 7.8% 7.8% 7.8% 7.8% 7.8% 7.8%   Bankruptcy risk   1.5% 4.9% 1.7% 1.1% 1.6% 0.8% 9.4% 9.4%   Credit score (0-100)   79 46 73 82 74 90 26 26   Credit rating   A BBB A A A AA BB BB   Credit limit (kDKK)   23.2 0.0 7.4 252.0 16.2 1,049.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,453 11,674 12,874 13,754 13,376 16,824 0.0 0.0   EBITDA   1,238 375 1,888 2,604 2,395 3,751 0.0 0.0   EBIT   1,120 238 1,715 2,470 2,294 3,634 0.0 0.0   Pre-tax profit (PTP)   1,097.4 183.4 1,681.3 2,409.6 2,257.0 3,621.8 0.0 0.0   Net earnings   851.8 136.8 1,307.2 1,872.2 1,754.9 2,821.9 0.0 0.0   Pre-tax profit without non-rec. items   1,097 183 1,681 2,410 2,257 3,622 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   260 342 374 256 377 336 0.0 0.0   Shareholders equity total   1,427 712 1,882 2,447 2,330 5,152 2,302 2,302   Interest-bearing liabilities   99.2 177 0.0 500 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,144 3,038 4,822 4,597 3,505 7,613 2,302 2,302   Net Debt   -978 -482 -2,242 -2,001 -1,494 -4,609 -2,302 -2,302     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,453 11,674 12,874 13,754 13,376 16,824 0.0 0.0   Gross profit growth   41.1% 11.7% 10.3% 6.8% -2.7% 25.8% -100.0% 0.0%   Employees   27 30 28 27 27 32 0 0   Employee growth %   35.0% 11.1% -6.7% -3.6% 0.0% 18.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,144 3,038 4,822 4,597 3,505 7,613 2,302 2,302   Balance sheet change%   31.6% -3.4% 58.7% -4.7% -23.8% 117.2% -69.8% 0.0%   Added value   1,238.3 374.8 1,887.8 2,603.8 2,427.9 3,750.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -147 -73 -160 -251 21 -158 -336 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.7% 2.0% 13.3% 18.0% 17.2% 21.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   40.5% 7.7% 43.6% 52.4% 56.6% 65.4% 0.0% 0.0%   ROI %   89.2% 19.5% 118.7% 100.5% 87.0% 97.2% 0.0% 0.0%   ROE %   71.6% 12.8% 100.8% 86.5% 73.5% 75.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   45.4% 23.4% 39.0% 53.2% 66.5% 67.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -79.0% -128.6% -118.8% -76.8% -62.4% -122.9% 0.0% 0.0%   Gearing %   7.0% 24.9% 0.0% 20.4% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   34.5% 39.6% 37.8% 24.3% 15.1% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.6 1.2 1.5 2.0 2.6 2.9 0.0 0.0   Current Ratio   1.6 1.2 1.5 2.0 2.6 2.9 0.0 0.0   Cash and cash equivalent   1,076.8 659.2 2,242.0 2,500.5 1,493.6 4,608.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,075.0 479.8 1,540.2 2,136.0 1,898.8 4,762.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   46 12 67 96 90 117 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   46 12 67 96 89 117 0 0   EBIT / employee   41 8 61 91 85 114 0 0   Net earnings / employee   32 5 47 69 65 88 0 0